Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05165056
NA

Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity

Sponsor: Jessa Hospital

View on ClinicalTrials.gov

Summary

This study aims to investigate the effectiveness of photobiomodulation therapy (PBMT) in the prevention and management of radiotherapy-induced vaginal toxicity (RIVT). Therefore, we hypothesize that PBMT can reduce the severity of RIVT in gynecological cancer patients, increasing the patient's QoL and sexual functioning.

Official title: Evaluating the Feasibility and Efficacy of Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity: a Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

62

Start Date

2022-08-24

Completion Date

2030-01

Last Updated

2023-09-29

Healthy Volunteers

No

Interventions

DEVICE

Intimleds

INTIMILEDS® is a photobiomodulation device designed for intravaginal use. It's design permits an irradiation of the whole vaginal wall, the vulva, and the cervix, with a constant intensity.

Locations (2)

Ziekenhuis Oost-Limburg

Genk, Limburg, Belgium

Jessa Hospital

Hasselt, Limburg, Belgium